A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT05377580 · COMPLETED
Trial details
- NCT number
- NCT05377580
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-06-21
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.